Bijoy Hans Ltd is in the business of Pharmaceutical, Medical and Cosmetics goodsBusiness Overview: Company does Wholesale of Pharmaceutical and Medical Goods and Cosmetics. It offers various pharmaceutical formulations such as tablets, capsules, syrups, suspension and powders, focusing on segments viz. Antibiotics, Cough/cold/allergy, H-1 receptor Antagonist (Antiulcerant), Nutraceutical, and NSAIDS
Date: 06.08.2025 To, The Manager, Department of Corporate Services, BSE Limited 1st Floor, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001 Ref: Bijoy Hans Limited (Script Code: 524723) Sub.: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations, 2015"). With reference to...
Bijoy Hans Limited has confirmed the dispatch of notices and the annual report for its 40th Annual General Meeting, which will be held virtually. This allows shareholders to engage and vote on crucial company matters from anywhere. The company is providing a remote e-voting facility, with the voting window opening...
Bijoy Hans Limited will hold its 40th Annual General Meeting virtually on August 25. Shareholders can participate via video or audio-visual means and utilize electronic voting. The company's share transfer books will be closed from August 18 to August 25. Bijoy Hans reported a net loss of Rs 0.43 lakh...
Bijoy Hans Limited has announced a board meeting on July 28, 2025, where it approved the financial results for the quarter ended June 30, 2025. The company reported a total income of 0.0112 Cr but recorded a net loss of 0.0017 Cr for the quarter. To strengthen its equity base,...
Bijoy Hans Limited has confirmed no deviation in the utilization of funds raised through a preferential issue for the quarter ended June 30, 2025. The company raised 5.625 Cr on May 27, 2025, and these funds were fully utilized as stated for business expansion, funding working capital requirements, and general...
